Copyright © 2015 - 2022 Lifecarenews.in
LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283
Alarming Rates of HIV and AIDS among Houston’s Blacks and
HOUSTON, April 27, 2023 (GLOBE NEWSWIRE) -- The statistics tell…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
HIV
ACTG Announces Publication of New Insights Into HIV
LOS ANGELES, March 27, 2023 (GLOBE NEWSWIRE) -- The AIDS…
Theratechnologies Presents New Tesamorelin Data
<!-- Name:DistributionId Value:8754713 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->
<!-- Name:IcbCode Value:4577 -->…
National AIDS Memorial Announces Recipients of the Mary
<!-- Name:DistributionId Value:8754709 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->
<!-- Name:IcbCode Value: -->…
AIDS Memorial Quilt Heads to New Orleans and Baton Rouge to
<!-- Name:DistributionId Value:8742309 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->
<!-- Name:IcbCode Value: -->…
Sunlenca® (lenacapavir) Receives FDA Approval as a First-in-Class, Twice-Yearly Treatment Option for…
– Sunlenca is the First and Only Approved Capsid Inhibitor-Based HIV Treatment Option –
– New Drug Application Approval Based on High Rates of Sustained Virologic Suppression in the CAPELLA Trial –
FOSTER CITY, Calif.--(BUSINESS…